1032 related articles for article (PubMed ID: 21711095)
21. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
[TBL] [Abstract][Full Text] [Related]
22. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.
Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G
Haematologica; 2001 Mar; 86(3):266-73. PubMed ID: 11255273
[TBL] [Abstract][Full Text] [Related]
23. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
[TBL] [Abstract][Full Text] [Related]
24. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.
Haerle SK; Strobel K; Hany TF; Sidler D; Stoeckli SJ
Head Neck; 2010 Mar; 32(3):319-25. PubMed ID: 19626642
[TBL] [Abstract][Full Text] [Related]
25. The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care.
Gordin A; Golz A; Keidar Z; Daitzchman M; Bar-Shalom R; Israel O
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):130-7. PubMed ID: 17599580
[TBL] [Abstract][Full Text] [Related]
26. Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.
Graafland NM; Leijte JA; Valdés Olmos RA; Hoefnagel CA; Teertstra HJ; Horenblas S
Eur Urol; 2009 Aug; 56(2):339-45. PubMed ID: 19477581
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/CT.
Choi JW; Yoon YH; Yoon YH; Kim SM; Koo BS
Ann Surg Oncol; 2011 May; 18(5):1306-11. PubMed ID: 21140231
[TBL] [Abstract][Full Text] [Related]
28. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M
J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897
[TBL] [Abstract][Full Text] [Related]
29. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study.
Yoon YC; Lee KS; Shim YM; Kim BT; Kim K; Kim TS
Radiology; 2003 Jun; 227(3):764-70. PubMed ID: 12773680
[TBL] [Abstract][Full Text] [Related]
30. Combined [18F]fluorodeoxyglucose positron emission tomography and computed tomography for detecting contralateral neck metastases in patients with head and neck squamous cell carcinoma.
Kim SY; Kim JS; Doo H; Lee H; Lee JH; Cho KJ; Choi SH; Nam SY; Roh JL
Oral Oncol; 2011 May; 47(5):376-80. PubMed ID: 21470899
[TBL] [Abstract][Full Text] [Related]
31. Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: preoperative planning for necessity and extent of neck dissection.
Kim MJ; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2013 Mar; 20(3):899-905. PubMed ID: 23161114
[TBL] [Abstract][Full Text] [Related]
32. The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.
Carlson ER; Schaefferkoetter J; Townsend D; McCoy JM; Campbell PD; Long M
J Oral Maxillofac Surg; 2013 Jan; 71(1):162-77. PubMed ID: 22742956
[TBL] [Abstract][Full Text] [Related]
33. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT.
Wartski M; Le Stanc E; Gontier E; Vilain D; Banal A; Tainturier C; Pecking AP; Alberini JL
Nucl Med Commun; 2007 May; 28(5):365-71. PubMed ID: 17414886
[TBL] [Abstract][Full Text] [Related]
34. 18F-FDG PET/CT makes a significant contribution to diagnosis of malignancy in patients with cervical lymphadenopathy: a study using optimal scale regression tests.
Ouyang L; Shi ZY; Lin ZG
Chin Med J (Engl); 2013 Feb; 126(4):659-67. PubMed ID: 23422185
[TBL] [Abstract][Full Text] [Related]
35. Metabolic tumour volume. Prognostic value in locally advanced squamous cell carcinoma of the head and neck.
Deron P; Mertens K; Goethals I; Rottey S; Duprez F; De Neve W; Vermeersch H; Van de Wiele C
Nuklearmedizin; 2011; 50(4):141-6. PubMed ID: 21594304
[TBL] [Abstract][Full Text] [Related]
36. The value of preoperative 18F-FDG PET/CT for the assessing contralateral neck in head and neck cancer patients with unilateral node metastasis (N1-3).
Joo YH; Yoo IR; Cho KJ; Park JO; Nam IC; Kim CS; Kim SY; Kim MS
Clin Otolaryngol; 2014 Dec; 39(6):338-44. PubMed ID: 25102759
[TBL] [Abstract][Full Text] [Related]
37. Advances in imaging in the work-up of head and neck cancer patients.
de Bree R; Castelijns JA; Hoekstra OS; Leemans CR
Oral Oncol; 2009 Nov; 45(11):930-5. PubMed ID: 19692289
[TBL] [Abstract][Full Text] [Related]
38. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
[TBL] [Abstract][Full Text] [Related]
39. Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome.
Dale E; Moan JM; Osnes TA; Bogsrud TV
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1015-1019. PubMed ID: 27671150
[TBL] [Abstract][Full Text] [Related]
40. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer.
Adams S; Baum RP; Stuckensen T; Bitter K; Hör G
Eur J Nucl Med; 1998 Sep; 25(9):1255-60. PubMed ID: 9724374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]